SCHEMBL9143

SCHEMBL9143

C1=C[N]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34926 0.90
SCHEMBL7498312 0.88
SCHEMBL7216416 0.88
SCHEMBL6178032 0.88
SCHEMBL5695369 0.79
SCHEMBL3315 0.79
SCHEMBL3068760 0.69
SCHEMBL76573 0.65
SCHEMBL8089337 0.60
SCHEMBL8089335 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3440 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118339151-A Compound for inhibiting or degrading BRD9, composition and pharmaceutical application thereof 西藏海思科制药有限公司 2024-07-12 CN claimed
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP claimed
US-12029739-B2 SHP2 inhibitor and use thereof KANAPH THERAPEUTICS INC. (KR) 2024-07-09 US claimed
EP-4385985-A1 HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-06-19 EP claimed
CN-118203585-A Pharmaceutical use of ENPP1 inhibitors 上海翊石医药科技有限公司 2024-06-18 CN claimed
US-20240189306-A1 SHP2 INHIBITOR AND USE THEREOF KANAPH THERAPEUTICS INC. (KR) 2024-06-13 US claimed
CN-117157299-B Tricyclic heterocyclic derivative, composition and application thereof 北京丹擎医药科技有限公司 2024-05-28 CN claimed
CN-118063435-A Piperidine-2, 6-dione derivative and application thereof 西藏海思科制药有限公司 2024-05-24 CN claimed
EP-4368625-A1 SHP2 INHIBITOR AND USE THEREOF Kanaph Therapeutics Inc. (KR) 2024-05-15 EP claimed
US-20240140954-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-05-02 US claimed
US-4663466-A Process for preparing substituted amino herbicides CHEVRON RESEARCH COMPANY (US) 1987-05-05 US claimed
EP-0198054-A1 PROCESS FOR PREPARING SUBSTITUTED AMINO HERBICIDES CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1986-10-22 EP claimed
US-4606756-A Herbicidal 2-(nitrogen heterocycle)5-amino-3-oxo-4-(substituted-phenyl)-2,3-dihydrofurans CHEVRON RESEARCH COMPANY (US) 1986-08-19 US claimed
WO-1986002643-A1 PROCESS FOR PREPARING SUBSTITUTED AMINO HERBICIDES CHEVRON RESEARCH COMPANY (US) 1986-05-09 WO claimed
US-4568375-A GOOD PRE-EMERGENCE ACTIVITY AGAINST A BROAD SPECTRUM OF BOTH BROAD LEAF PLANTS AND GRASSY PLANTS CHEVRON RESEARCH COMPANY (US) 1986-02-04 US claimed
EP-0014402-B1 NOVEL 20-0-ACYLMAYTANSINOIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Takeda Chemical Industries, Ltd. (JP) 1983-07-20 EP claimed
US-4307016-A FUNGICIDES, PROTOZOACIDES OR ANTITUMOR AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-22 US claimed
US-4294757-A BLEACHING CELLULOSE FIBERS AND ADDITION OF ALKALI METAL POLYPHOSPHATES AND ALKALI METAL DIETHYLENETRIAMINE PENTA(METHYLENE PHOSPHONAT) TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1981-10-13 US claimed
US-4256746-A ANTITUMOR AGENTS; MICROBIOCIDES; MITOSIS TAKEDA CHEMICAL INDUSTRIES (JP) 1981-03-17 US claimed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US claimed